MHC MACSimer B*0702 Control, human has been developed for the reliable exclusion of unspecific background signals during the detection and isolation of antigen-specific T cells using MHC MACSimers via flow cytometry. MHC MACSimer Control reagents are offered in various human and murine MHC allele variants to match our MHC product portfolio. They are recommended to be used as a negative staining control when analyzing antigen-specific T cells using Peptide-loaded MHC MACSimers or MHC MACSimer FleX Kits, e.g., in the context of T cell receptor (TCR) epitope screening, TCR-T cell therapy devel
Related products for MHC MACSimer B*0702 Control, human
MHC MACSimer B*0702 Control, human has been developed for the reliable exclusion of unspecific background signals during the detection and isolation of antigen-specific T cells using MHC MACSimers via flow cytometry. MHC MACSimer Control reagents are offered in various human and murine MHC allele variants to match our MHC product portfolio. They are recommended to be used as a negative staining control when analyzing antigen-specific T cells using Peptide-loaded MHC MACSimers or MHC MACSimer FleX Kits, e.g., in the context of T cell receptor (TCR) epitope screening, TCR-T cell therapy development, or immune response monitoring.
For users seeking deep technical insight, a comprehensive MHC handbook is available, covering relevant scientific details and experimental protocols, along with expert tips and troubleshooting guidance:
Technical specifications
Detection of cytomegalovirus (CMV)-reactive antigen-specific CD8+ T cells using MHC MACSimer A*0201 CMV pp65 (NLVPMVATV), human, PE. Human PBMCs derived from a healthy HLA-A*0201+ blood donor were stained using MHC MACSimer A*0201 Control, human, PE (upper left). CMV-specific T cells were detected using peptide-loaded MHC MACSimer A*0201 CMV pp65 (NLVPMVATV), human, PE (upper middle). MHC MACSimers were released from the cells of interest using REAlease® Technology (upper right). Fluorescence minus one (FMO) staining served as an additional control (lower left). CD8-FITC co-staining was performed using CD8 Antibody, anti-human, REAfinity™. Flow cytometry analyses were done using the MACSQuant® Analyzer.
To access a Certificate of Analysis (CoA) follow the link below and enter the specific lot of your product.
Should you wish to request additional documentation, such as a Safety Data Sheet (SDS) in other languages than English or Swedish, an SDS-replacement document, or a Certificate of Origin (CoO), please direct your inquiry to your local technical support team.
You have previously chosen International as your location.
What do you want to do?